GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC (MIC:GEMA) » Definitions » Beneish M-Score

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC (MIC:GEMA) Beneish M-Score : -2.03 (As of May. 26, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.03 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's Beneish M-Score or its related term are showing as below:

MIC:GEMA' s Beneish M-Score Range Over the Past 10 Years
Min: -4.07   Med: -2.23   Max: 0.83
Current: -2.03

During the past 8 years, the highest Beneish M-Score of Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC was 0.83. The lowest was -4.07. And the median was -2.23.


Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC Beneish M-Score Historical Data

The historical data trend for Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC Beneish M-Score Chart

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Get a 7-Day Free Trial -2.17 -2.29 -4.07 0.83 -2.03

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23 Dec23
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.83 - - -2.03

Competitive Comparison of Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's Beneish M-Score

For the Medical Care Facilities subindustry, Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's Beneish M-Score Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's Beneish M-Score falls into.



Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.5803+0.528 * 0.9594+0.404 * 0.9594+0.892 * 1.1132+0.115 * 10.703
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.4154+4.679 * -0.076688-0.327 * 0.7342
=-2.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Total Receivables was ₽31.3 Mil.
Revenue was ₽283.5 Mil.
Gross Profit was ₽235.6 Mil.
Total Current Assets was ₽243.9 Mil.
Total Assets was ₽1,277.8 Mil.
Property, Plant and Equipment(Net PPE) was ₽49.1 Mil.
Depreciation, Depletion and Amortization(DDA) was ₽0.7 Mil.
Selling, General, & Admin. Expense(SGA) was ₽62.9 Mil.
Total Current Liabilities was ₽179.5 Mil.
Long-Term Debt & Capital Lease Obligation was ₽245.7 Mil.
Net Income was ₽125.8 Mil.
Gross Profit was ₽0.0 Mil.
Cash Flow from Operations was ₽223.8 Mil.
Total Receivables was ₽48.4 Mil.
Revenue was ₽254.7 Mil.
Gross Profit was ₽203.0 Mil.
Total Current Assets was ₽135.0 Mil.
Total Assets was ₽870.2 Mil.
Property, Plant and Equipment(Net PPE) was ₽36.2 Mil.
Depreciation, Depletion and Amortization(DDA) was ₽6.0 Mil.
Selling, General, & Admin. Expense(SGA) was ₽39.9 Mil.
Total Current Liabilities was ₽141.7 Mil.
Long-Term Debt & Capital Lease Obligation was ₽252.6 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(31.275 / 283.512) / (48.415 / 254.677)
=0.110313 / 0.190104
=0.5803

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(203.004 / 254.677) / (235.563 / 283.512)
=0.797104 / 0.830875
=0.9594

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (243.89 + 49.118) / 1277.808) / (1 - (134.999 + 36.183) / 870.153)
=0.770695 / 0.803274
=0.9594

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=283.512 / 254.677
=1.1132

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(6.005 / (6.005 + 36.183)) / (0.662 / (0.662 + 49.118))
=0.142339 / 0.013299
=10.703

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(62.854 / 283.512) / (39.892 / 254.677)
=0.221698 / 0.156638
=1.4154

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((245.688 + 179.503) / 1277.808) / ((252.614 + 141.738) / 870.153)
=0.33275 / 0.453198
=0.7342

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(125.78 - 0 - 223.773) / 1277.808
=-0.076688

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC has a M-score of -2.03 suggests that the company is unlikely to be a manipulator.


Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC (MIC:GEMA) Business Description

Traded in Other Exchanges
N/A
Address
St. Gubkina, 3, Building 1, Floor 1, Pom. I, r. 24, Moscow, RUS, 119333
Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC, through its subsidiary, is engaged in offering personal storage of cord blood stem cells in Russia and Eastern Europe. The services provided by the company include Cord Blood Cell Preservation, Program for the treatment of Cerebral Palsy, Cord Blood DNA isolation and Umbilical cord tissue among others.

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC (MIC:GEMA) Headlines

No Headlines